Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection.
American Airlines on Tuesday announced a merged frequent-flier program for US Airways customers and its own, and will combine loyalty accounts next year.
With the latest approval announced Tuesday, IBM has authorized the repurchase of as much as $6.4 billion in stock.
The Federal Trade Commission says AT&T failed to adequately disclose to customers that it would reduce data speeds if they went over a certain amount of data use in a billing cycle.
The bank has already axed tens of thousands of staff since the 2008 financial crisis that triggered a multi-illion-pound state bailout.
DuPont posted better-than-expected earnings for its third quarter, but its sales missed analysts' estimates.
Shares of Kohl's skidded Tuesday after the department store operator said sales weakened in October and its profit for the year will be at the low end of its forecast.
Aetna became the latest major health insurer to thump analyst expectations for the third quarter and then raise its forecast for 2014.
Amgen is expanding its plans to cut jobs next year even as it looks to stock repurchases and higher dividends to return about 60 percent of its adjusted earnings to shareholders through 2018.
Twitter's third-quarter revenue outpaced expectations, but investors concerned about user growth and holiday-quarter revenue cut the company's stock price late Monday.
Amgen said Monday it plans to cut 2,925 jobs by the end of 2015 to streamline operations, reduce management layers and shrink its real estate footprint.
Dunkin' Donuts plans to roll out a croissant-doughnut hybrid in the U.S. next week, but the company says please don't call it a "Cronut."
For the first time since 2010, participation in workplace-based retirement plans grew in 2013.
State-owned oil giant Petroleos Mexicanos said it signed a cooperation agreement with U.S. supermajor Chevron Corp. to seek petroleum industry opportunities that are beneficial for both parties.
The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox.